These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29263783)

  • 1. Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials.
    Lieberman F
    F1000Res; 2017; 6():1892. PubMed ID: 29263783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topics in chemotherapy, molecular-targeted therapy, and immunotherapy for newly-diagnosed glioblastoma multiforme.
    Okonogi N; Shirai K; Oike T; Murata K; Noda SE; Suzuki Y; Nakano T
    Anticancer Res; 2015 Mar; 35(3):1229-35. PubMed ID: 25750269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?].
    Schernberg A; Marabelle A; Massard C; Armand JP; Dumont S; Deutsch E; Dhermain F
    Bull Cancer; 2016 May; 103(5):484-98. PubMed ID: 27032303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions in glioblastoma therapy.
    Colman H
    Am Soc Clin Oncol Educ Book; 2012; ():108-11. PubMed ID: 24451718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
    Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
    J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
    Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
    Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How treatment monitoring is influencing treatment decisions in glioblastomas.
    Neagu MR; Huang RY; Reardon DA; Wen PY
    Curr Treat Options Neurol; 2015 Apr; 17(4):343. PubMed ID: 25749847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging immunotherapies for glioblastoma.
    Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma.
    Jin K; Mao C; Chen L; Wang L; Liu Y; Yuan J
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33435205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.
    Hyare H; Thust S; Rees J
    Curr Treat Options Neurol; 2017 Mar; 19(3):11. PubMed ID: 28349351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression.
    Losurdo A; Di Muzio A; Cianciotti BC; Dipasquale A; Persico P; Barigazzi C; Bono B; Feno S; Pessina F; Santoro A; Simonelli M
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological Imaging Methods for Evaluating Response to Immunotherapies in Glioblastomas.
    Chawla S; Shehu V; Gupta PK; Nath K; Poptani H
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma multiforme: State of the art and future therapeutics.
    Wilson TA; Karajannis MA; Harter DH
    Surg Neurol Int; 2014; 5():64. PubMed ID: 24991467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme.
    Chinot OL; de La Motte Rouge T; Moore N; Zeaiter A; Das A; Phillips H; Modrusan Z; Cloughesy T
    Adv Ther; 2011 Apr; 28(4):334-40. PubMed ID: 21432029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme.
    Raizer JJ
    J Neurooncol; 2005 Aug; 74(1):77-86. PubMed ID: 16078112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches and mechanisms of immunotherapy for glioblastoma.
    Hegde M; Bielamowicz KJ; Ahmed N
    Discov Med; 2014 Mar; 17(93):145-54. PubMed ID: 24641957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel treatment for glioblastoma: integrin inhibition.
    Chamberlain MC; Cloughsey T; Reardon DA; Wen PY
    Expert Rev Neurother; 2012 Apr; 12(4):421-35. PubMed ID: 22449214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma.
    Thomas JG; Rao G; Kew Y; Prabhu SS
    Neurosurg Focus; 2016 Oct; 41(4):E12. PubMed ID: 27690657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.